Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly's in trial
- Posted on February 23, 2026
- By CNBC
- 6 Views
Novo Nordisk sinks 10% after weight loss drug fails to match Eli Lilly's in trial
Novo Nordisk stock fell as much as 10% Monday after it said its next-generation weight loss drug didn't meet its primary target.
